Pfizer fight with Starboard heats up, hedge fund alleges executive pressure
The corporate clash between Pfizer and Starboard Value heated up on Thursday when the activist investment firm pressed the U.S. drugmaker to investigate actions by its board, after two former executives backed out of its campaign against the company.
FDA, Pfizer and Hemophilia
Some misleading narratives about Bourla’s leadership that have been put forward have been distinctly unfair,' write Jeff ...
Pfizer shares are on the up since US activist investor Starboard Value built up a stake in the drug maker. But strategic ...
Since 2011, Starboard Value's Jeff Smith has extracted board seats and profits from corporate America — by force if necessary ...
Every investor in Pfizer Inc. ( NYSE:PFE) should be aware of the most powerful shareholder groups. We can see that ...
Pfizer (PFE) stock may present opportunities for patient investors. Read how this biotech giant may deliver long-term ...
The ongoing corporate battle between Pfizer and activist investment firm Starboard Value escalated on Thursday when Starboard ...
Summit County's Department of Health announced clinics in Akron are now offering the new Pfizer COVID-19 vaccine.
Pfizer remains an attractive capital return play with a 10X P/E ratio, despite concerns about post-COVID revenue declines.
Pfizer ($PFE) has long been a staple in the portfolios of income-oriented investors, especially those drawn to its consistent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback